Praxis Precision Medicines share price logo

Praxis Precision Medicines

NASDAQ: PRAX

Mid Cap

$300.43

-10.47

(-3.37%)

as on

Praxis Precision Medicines Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $298.54
    $314.15
    downward going graph

    0.63%

    Downside

    4.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $160.11
    $392.70
    downward going graph

    46.71%

    Downside

    30.71%

    Upside

    downward going graph

Praxis Precision Medicines share price movements today

Previous Close
$310.90
Open
$308.50
Volume
460.0K
Market Cap
$9.2B
Day's Low - High
$298.54 - $314.15
52 Week Low - High
$160.11 - $392.70

Praxis Precision Medicines Historical Returns

1 Month Return
+ 17.14 %
3 Month Return
-20.09 %
1 Year Return
+ 76.93 %
3 Year Return
+ 1771.84 %
5 Year Return
+ 7.28 %

Praxis Precision Medicines Stock Fundamentals & Key Indicators

Check Praxis Precision Medicines market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.2B

EPS (TTM)

-12.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-24.25

Industry PE ratio

-14.50

PEG Ratio

-81.49

EBITDA

-359.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-29.41%

Praxis Precision Medicines vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Praxis Precision Medicines with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$9.2B7.28%-24.250.00%0.00%
Neutral$80.7B-26.07%-28.1528.00%0.00%
StrongBuy$45.7BNA65.0988.39%0.00%
StrongBuy$132.0B181.62%33.2585.53%0.00%
Buy$95.5B41.06%19.6585.77%0.41%

Stock Returns calculator for Praxis Precision Medicines Stock including INR - Dollar returns

The Praxis Precision Medicines stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Praxis Precision Medicines investment value today

Current value as on today

₹1,83,922

Returns

₹83,922

(+83.92%)

Returns from Praxis Precision Medicines Stock

₹76,932 (+76.93%)

Dollar Impact

₹6,990 (+6.99%)

Analyst Recommendation on Praxis Precision Medicines Stock

Based on 10 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Praxis Precision Medicines. Average target price of $674.25

Praxis Precision Medicines Share Price Target

Get share price movements and forecasts by analysts on Praxis Precision Medicines.

What analysts predicted

55.44%UPSIDE

Target Price

$674.25

Current Price

$300.43

Analyzed by

10 Analysts

High

$1201

Target

$674.25

Low

$478

Praxis Precision Medicines target price $674.25, a slight upside of 55.44% compared to current price of $300.43. According to 10 analysts rating.

Indian Investors' Interest in Praxis Precision Medicines Stock

Investment in Praxis Precision Medicines Shares on INDmoney has grown by 231.25% in the last 30 days, indicating increased investment activity.

Time period: to

Change:231.25% versus previous 30 day period

Search interest for Praxis Precision Medicines Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Praxis Precision Medicines Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
0
0
7
-
-
-
-
-
-
-
Gross Profit
-26
-41
-48
-60
-63
-65
-77
0
-
-
Operating Income
-37
-56
-63
-74
-76
-78
-97
-105
-96
-106
EBITDA
-32
-51
-58
-69
-71
-73
-88
-92
-83
-94
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-32
-51
-58
-69
-71
-73
-88
-92
-83
-94
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-32
-51
-58
-69
-71
-73
-88
-92
-83
-94
Net Profit Margin
-7535.85%
-13767.88%
-654.23%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Praxis Precision Medicines Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
2
8
-
Gross Profit
0
0
-
-
-154
-84
-143
0
Operating Income
-22
-35
-61
-167
-214
-126
-200
-326
EBITDA
-26
-34
-61
-166
-213
-122
-182
-303
Interest Expense
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-26
-35
-61
-167
-214
-123
-182
-303
Income Tax Expense
0
0
0
-
-
-
-
-
Net Income
-26
-35
-61
-167
-214
-123
-182
-303
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-3445.81%
-1681.98%
0.00%

Praxis Precision Medicines Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-32
-51
-58
-69
-71
-73
-88
-92
-83
-94
Operating Cash Flow
-27
-27
-56
-52
-54
-64
-77
-86
-77
-81
Investing Cash Flow
-195
49
-10
-51
17
50
-328
-344
10
-32
Financing Cash Flow
216
1
113
53
28
6
613
609
3
0
Change in Cash
-6
23
46
-49
-8
-7
207
179
-63
-112

Praxis Precision Medicines Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-35
-61
-167
-214
-123
-182
-303
Operating Cash Flow
-20
-32
-52
-124
-185
-111
-131
-249
Investing Cash Flow
0
0
-
-140
96
38
-248
-311
Financing Cash Flow
37
59
304
107
10
91
514
702
Change in Cash
17
26
251
-157
-77
19
134
141

Global Institutional Holdings in Praxis Precision Medicines

Check out the Institutions with significant holdings in Praxis Precision Medicines.

Funds
Holdings
Shares Held
Vanguard
8.17%
2284851
BlackRock, Inc.
7.99%
2232814
VANGUARD INDEX FUNDS
7.98%
2230873
Joseph Edelman
7.24%
2024781
Felix Baker
6.27%
1753198

Praxis Precision Medicines News & Key Events

  • img

    Today's Timeline - 12 November

    Thu, 05:43 PM

    -

    Praxis reports Q3 2026 results; NDA for relutrigine under FDA review with PDUFA date set for December 27, 2026.

    Fri, 04:34 AM

    -

    Praxis outlines commercial strategy, updates on ulixacaltamide and relutrigine, and introduces new pipeline programs.

Insights on Praxis Precision Medicines

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PRAX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, PRAX stock has moved up by 1672.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 722.1% return, outperforming this stock by 645.2%

About Praxis Precision Medicines

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which is currently in Phase IIa clinical trials for addressing both major depressive disorder and perimenopausal depression. Additionally, PRAX-944, a small molecule designed to selectively inhibit T-type calcium channels, is also progressing through Phase IIa clinical trials to manage essential tremor. Beyond these, Praxis is also advancing a pipeline of other promising drug candidates, such as: PRAX-562, a persistent sodium current blocker, undergoing Phase I clinical evaluation for treating severe pediatric epilepsy and adult cephalgia (headaches). PRAX-222, an antisense oligonucleotide (ASO) aimed at individuals suffering from gain-of-function (GOF) SCN2A epilepsy. And a program targeting KCNT1 for the treatment of KCNT1 GOF epilepsy. To further its research and development efforts, Praxis maintains several strategic alliances. These include a cooperation and licensing arrangement with RogCon Inc.; a licensing deal with Purdue Neuroscience Company; a comprehensive research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and a collaborative project with The Florey Institute focused on the creation of three new antisense oligonucleotides (ASOs). Established in 2015, the company's headquarters are situated in Boston, Massachusetts.
OrganisationPraxis Precision Medicines
Headquarters99 High Street, Boston, MA, 02110, US
IndustryBiotechnology
CEOMarcio Silva De'Souza

Key Management of Praxis Precision Medicines

Name

Title

Mr. Alex Nemiroff J.D.

General Counsel & Secretary

Ms. Megan T. Sniecinski

Chief Operating Officer

Ms. Alyssa J. S. Wyant

Chief Regulatory & Quality Officer

Mr. Brian Spar

Chief of Staff

Dr. Orrin Devinsky M.D., Ph.D.

Head of Clinical Strategy

Mr. Timothy Edwin Kelly

CFO & Treasurer

Dr. Steven Petrou B.Sc. (Hons.), Ph.D.

Co-Founder and President of Research & Development

Dr. Karl Hansen Ph.D.

Chief Technical Operations Officer

Ms. Kelly McCue

Chief People Officer

Mr. Marcio Silva De'Souza M.B.A.

President, CEO & Director

FAQs

What is Praxis Precision Medicines share price today?

Praxis Precision Medicines share price today is $300.43 as on at the close of the market. Praxis Precision Medicines share today touched a day high of $314.15 and a low of $298.54.

What is the 52 week high and 52 week low for Praxis Precision Medicines share?

Praxis Precision Medicines share touched a 52 week high of $392.70 on and a 52 week low of $160.11 on . Praxis Precision Medicines stock price today i.e. is closed at $300.43,which is 23.50% down from its 52 week high and 87.64% up from its 52 week low.

What is Praxis Precision Medicines's market capitalisation today?

Praxis Precision Medicines market capitalisation is $0.01T as on .

How to invest in Praxis Precision Medicines Stock (PRAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Praxis Precision Medicines on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Praxis Precision Medicines Stock (PRAX) from India?

Indian investors can start investing in Praxis Precision Medicines (PRAX) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Praxis Precision Medicines stock (as per the Rupee-Dollar exchange rate as on ). Based on Praxis Precision Medicines share’s latest price of $300.43 as on November 21, 2026 at 8:46 am IST, you will get 0.0333 shares of Praxis Precision Medicines. Learn more about fractional shares .

What are the returns that Praxis Precision Medicines has given to Indian investors in the last 5 years?

Praxis Precision Medicines stock has given 7.28% share price returns and 25.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?